Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study
Table 2
Comparison of baseline clinical characteristics of the three groups.
Surgical
Endovascular
Hybrid
p
n=391
n=502
n=129
Age (yrs)
70.8±8.6
73.1±8.0
71.5±8.1
.001
Male gender
296 (75.7%)
367 (73.1%)
90 (69.8%)
.62
Hypertension
341 (87.2%)
442 (88.0%)
107 (82.9%)
.24
Diabetes
168 (43.0%)
168 (33.5%)
46 (35.7%)
.01
CKD
118 (30.3%)
112 (22.4%)
24 (18.4%)
.01
Left ventricle ejection fraction
56.1±8.0
54.1±8.6
51.3±8.9
.001
Bilateral COD
30 (7.7%)
97 (19.4%)
42 (32.9%)
.001
Multivessel CAD
264 (67.5%)
235 (46.8%)
89 (69.0%)
.001
Acute coronary syndrome
77 (19.7%)
110 (21.9%)
36 (27.9%)
.23
Neurological symptoms
63 (16.1%)
86 (17.2%)
43 (33.3%)
.001
Values are n (%) or mean ± SD. =Endovascular versus Surgical and Hybrid; =Surgical versus Endovascular and Hybrid; =Hybrid versus Surgical and Endovascular. CAD=coronary artery disease; CKD=chronic kidney disease; COD= carotid obstructive disease.
